If you have been reading about Reconstitution time and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-01. Numbers and descriptions here follow the published literature rather than marketing material.
Lyophilized solids are often hygroscopic, so handling occurs in controlled low-humidity areas or glove boxes when the material is exposed. Vials remain sealed with elastomeric stoppers and aluminum crimps until use, because airborne moisture can raise residual water and shorten shelf life. The porous cake is fragile and may crack, shrink, or powder during transport. Personnel typically avoid repeated warming and cooling of sealed units, which can draw moisture through closures. These practices aim to preserve the low water content achieved during drying.
Storage conditions depend on the formulation and the intended shelf life. Many pharmaceutical and biological freeze-dried products are kept at 2–8 °C, while some stable foods and reagents tolerate room temperature. Others require −20 °C or colder to slow chemical degradation or aggregation. Protection from light and oxygen is common because oxidation can continue in the dry state. Stability studies usually monitor potency, appearance, moisture, and reconstitution time over months or years. Predictions from accelerated studies are useful but may not fully capture real-time changes.
Lyophilization removes water by freezing a material and then lowering pressure so ice changes directly to vapor. The process relies on sublimation, the phase transition from solid to gas without an intermediate liquid state. Because the material remains frozen during primary drying, the structure often stays porous. This porous matrix can rehydrate quickly when water is added back. The low pressure also allows vapor to leave the solid matrix without boiling.
A typical cycle begins with freezing, which fixes the material into a solid and determines ice crystal size. Primary drying then raises heat under vacuum so ice sublimes, often near or below the collapse temperature of the formulation. Secondary drying removes bound water that remains after ice is gone, usually by gently warming the product. Each stage balances heat input against pressure to avoid melting or structural damage. Temperature probes and pressure sensors guide the transition between stages.
In practice, lyophilization is slower and more energy intensive than simple drying. Cycle times can range from hours to several days depending on load, container, and formulation. Amorphous materials may require excipients that help preserve structure during freezing and drying. The method is widely used for biological materials, pharmaceuticals, and foods where heat drying would cause unacceptable change. Open questions remain about scaling cycles between laboratory and production equipment, and this gap affects technology transfer.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | 2–8 °C | Some products tolerate room temperature or require −20 °C. |
| Residual moisture method | Karl Fischer titration | Coulometric or volumetric; specific for water. |
| Cake appearance | Uniform porous plug | Collapse, shrinkage, or meltback indicates process deviation. |
| Reconstitution time | Seconds to several minutes | Depends on cake porosity, diluent, and formulation. |
| Primary container | Glass vial with elastomeric stopper | Crimp seal limits moisture ingress. |
Stability of a lyophilized product depends on its glass transition temperature, the temperature at which the amorphous cake transitions from a glassy to a rubbery state. Storage below this temperature minimizes molecular mobility and slows chemical degradation. If the storage temperature exceeds the glass transition temperature, the cake may collapse, shrink, or become sticky. Accelerated stability studies at elevated temperatures and humidity help predict shelf life, but they do not always reflect real-time behavior. Residual moisture content also plays a critical role in long-term stability.
Reconstitution involves adding a suitable diluent, often sterile water or a buffer, to the dried cake. Gentle swirling or inversion helps dissolve the material without creating excessive foam. The time required for complete dissolution can range from seconds to several minutes and depends on the cake structure and the diluent. Improper reconstitution, such as vigorous shaking or using the wrong diluent, can cause protein aggregation or loss of activity. After reconstitution, the product may have a limited shelf life and should be used according to its labeling.
Lyophilization is a drying process in which a solvent, usually water, is removed from a frozen material by sublimation under reduced pressure. The material is first solidified, then placed under vacuum so that ice transitions directly to vapor without a bulk liquid phase. This approach suits heat-sensitive substances that would degrade during conventional evaporation. Primary drying removes unbound ice, while secondary drying reduces water that remains adsorbed to the solid matrix. The result is a porous, lightweight solid that can be reconstituted later.
A typical cycle begins with freezing, sometimes including an annealing step to control ice crystal size. Freezing conditions influence the pore network that later allows vapor escape. During primary drying, shelf temperature and chamber pressure are set so heat enters the product while its temperature stays below the collapse or eutectic point. Secondary drying then raises the shelf temperature to desorb bound water and lower residual moisture. Cycle design depends on formulation, fill volume, container type, and equipment capability.
The physics of lyophilization couples heat transfer, mass transfer, and phase behavior. Sublimation requires a vapor pressure difference between the ice front and the chamber, and the dried layer adds resistance to vapor flow. Amorphous formulations are characterized by a glass transition temperature of the maximally freeze-concentrated solute, often denoted Tg'. Crystalline bulking agents can provide structure, while amorphous excipients stabilize labile components. Open questions remain about spatial heterogeneity, edge effects, and how laboratory cycles scale to production.
Quality assessment of a lyophilized product includes cake appearance, residual moisture, reconstitution time, and container closure integrity. A uniform, porous cake suggests that freezing and drying stayed within the formulation's design space. Cracks, shrinkage, meltback, or a glassy film can indicate thermal abuse or a formulation problem. Analysts also test for subvisible particles and sterility when the product requires those specifications. Visual inspection alone cannot confirm biological activity or chemical stability, so it is combined with analytical methods.
Stability programs monitor lyophilized products under defined temperature and humidity conditions over time. Real-time studies at recommended storage conditions are the reference, while accelerated studies provide early signals of degradation pathways. Because a dry cake can still undergo oxidation, hydrolysis, or aggregation, stability depends on residual moisture, excipients, and container headspace. Open questions include how best to predict long-term stability from short accelerated runs and how vial-to-vial variability affects shelf life. Current guidance treats these predictions as product-specific rather than universally generalizable.
Freeze-dried materials are hygroscopic to varying degrees and can take up moisture after drying. Storage therefore often uses sealed glass vials, rubber stoppers, and crimp seals to limit contact with ambient humidity. A desiccant may be included for moisture-sensitive products, although it is not universal. Controlled room temperature is sufficient for many lyophilizates, while others require refrigeration or freezing. Moisture ingress remains a primary cause of cake collapse, chemical degradation, and loss of reconstitution performance.
Lyophilization, also called freeze-drying, is a dehydration process in which a solvent, usually water, is frozen and then removed by sublimation under reduced pressure. The method preserves heat-sensitive materials that would degrade in conventional drying. Large-scale use grew during the mid-twentieth century for blood plasma and antibiotics, and it later expanded to vaccines, enzymes, foods, and advanced materials. The process produces a dry, porous solid that usually reconstitutes rapidly. It is distinct from simple evaporation because the solvent bypasses the liquid phase during primary removal.
The process generally proceeds in three stages: freezing, primary drying, and secondary drying. During freezing, controlled cooling converts water into ice and may also crystallize or vitrify solutes. In primary drying, the pressure is lowered below the triple point, and heat is supplied so ice sublimes directly to vapor. Secondary drying removes water that remains bound to the solid matrix, yielding a low final water content. Product temperature must stay below the collapse or glass transition temperature to maintain structure. Cycle design therefore balances shelf temperature, chamber pressure, and time.
Freeze-drying is used for materials whose activity or structure depends on low temperature and low water content. Examples include certain biologics, diagnostic reagents, starter cultures, coffee, and porous inorganic precursors. The dried product forms a cake whose porosity aids rapid wetting and dissolution. Main drawbacks are high energy use, long cycle times, and sensitivity to formulation and equipment variation. Questions remain about how freezing rates and ice morphology affect batch uniformity, especially when moving from laboratory to production scale.
=== Mechanism of action === The mechanism of action of methocarbamol in humans has not been conclusively established. Its effect is thought to be localized to the central nervous system rather than a direct effect on skeletal muscles. It does not affect the motor end plate or the peripheral nerve fiber. The efficacy of the medication is likely related to its sedative effect. It has been shown in animal studies to act as a blocker of Nav1.4 voltage-gated sodium channels, but this may not be its only target.
== Toxicity == Buformin was withdrawn from the market in many countries due to an elevated risk of causing lactic acidosis (although not the US, where it was never sold). Buformin is still available and prescribed in Romania (timed release Silubin Retard is sold by Zentiva), Hungary, Taiwan and Japan (sold by Nichi-Iko Pharmaceutical Co., Ltd as "DIBETOS" tablets, each containing 50 mg buformin hydrochloride). The lactic acidosis occurred only in patients with a buformin plasma level of greater than 0.60 μg/mL and was rare in patients with normal renal function. In one report, the toxic oral dose was 329 ± 30 mg/day in 24 patients who developed lactic acidosis on buformin. Another group of 24 patients on 258 ± 25 mg/day did not develop lactic acidosis on buformin.
Stationarity implies that the marginal (equilibrium) probabilities of nucleotides or amino acids remain constant over time. In a phylogenetic tree, this means the base composition is assumed to be the same across all lineages. Reversibility indicates that the process of substitution is symmetric in time. Formally, the probability of being in state i and changing to state j equals the probability of being in state j and changing to state i under the stationary distribution. This property allows the tree likelihood to be computed without knowledge of the root position. Homogeneity means that the substitution process (i.e., the rate matrix and stationary distribution) is the same across all branches of the tree. These assumptions enable the use of a single Markov model across the phylogeny and greatly reduce the complexity of tree estimation. Reversibility, in particular, is commonly used because it simplifies the likelihood calculations by removing the need to infer the root.
Sources: en.wikipedia.org
=== Crystal modification === Some antiscalants alter the crystal structure of scale-forming salts, making them less likely to adhere to surfaces and form stubborn deposits. At a submicroscopic level, these soft non-adherent scales with antiscalant use would appear distorted, more oval in shape, and less compact.
Ukraine claimed that the armored strength of the Russian Southern Group of Forces had decreased "significantly" to 650 tanks, including those damaged or otherwise disabled, and total number of AFVs deployed was "no more than" 1,850 vehicles.
Pathologist: A physician who specializes in diagnosing disease through the examination of human tissues and bodily fluids. Pathologists' Assistant: A master's level, certified professional with specialized training in human anatomy. These professionals perform autopsies, screen histopathology slides, and create physical descriptions of surgical specimen. Scientists/Technologists: Certified laboratory professionals with at least a Bachelor's degree level of education. Scientists in the fields of Blood Banking, Microbiology, Cytogenetics, Chemistry, Hematology, Molecular Biology, Andrology, etc. Medical Technologist, Medical Laboratory Scientist, Clinical Laboratory Scientist (MT, MLS or CLS). Histotechnologist: Scientists who specialize in the analysis of human tissues. Cytotechnologist: Scientists who specialize in the analysis of human cells. Technicians: Certified laboratory professionals with an Associate's level of education. Medical Laboratory Technician or Clinical Laboratory Technician (MLT or CLT) Histotechnicians Grossing Technician Phlebotomist (PBT): A certified healthcare professional who performs venipuncture. Medical Laboratory Assistant or Laboratory Assistant (MLA, LA): Medical laboratory assistants play a critical role in assisting with laboratory operations. They are often responsible for interacting with interdisciplinary healthcare professionals and maintaining specimen integrity Transcriptionist
CPA is generally well-tolerated and has a mild side-effect profile regardless of dosage when it is used in combination with an estrogen in women. Side effects of CPA in general include hypogonadism (low sex-hormone levels) and associated symptoms such as demasculinization, sexual dysfunction, infertility, and osteoporosis (fragile bones); breast changes such as breast tenderness, breast enlargement, and gynecomastia (breasts in men); emotional changes such as fatigue and depression; and other side effects such as vitamin B12 deficiency, weak glucocorticoid effects, and elevated liver enzymes. Weight gain can occur with CPA when it is used at high doses. Some of the side effects of CPA can be improved or fully prevented if it is combined with an estrogen to prevent estrogen deficiency. Few quantitative data are available on many of the potential side effects of CPA. Pooled tolerability data for CPA is not available in the literature. Cyproterone is also known to suppress adrenocortical function. At very high doses in aged men with prostate cancer, CPA can cause cardiovascular side effects. Rarely, CPA can produce blood clots, liver toxicity (including hepatitis, liver failure, and liver cancer), excessively high prolactin levels, and certain benign brain tumors including meningiomas (tumors of the meninges) and prolactinomas (prolactin-secreting tumors of the pituitary gland). Upon discontinuation from high doses, CPA can produce adrenal insufficiency as a withdrawal effect.
Sources: en.wikipedia.org
Therefore, the only option for GAHT may be self-administered medications (testosterone, oestrogen, anti-androgens,..etc.), without professional guidance. An examination of the use of self-medication found that people who self-medicated were more likely to experience adverse health effects from preexisting conditions such as high blood pressure as well as slower development of desired secondary sex characteristics. Transgender people seeking surgery may be informed they will need to take hormones for the rest of their life if they want to maintain the feminizing effects of oestrogen or the masculinizing effects of testosterone. Their dose of hormones will usually be reduced, but it should still be enough to produce the effects that they need and to keep them well, and to protect them against osteoporosis (thinning of the bones) as they get older. If they are still on hormone blockers, they will stop taking them altogether.
Risk of developing CJD increases with age. CJD incidence was 3.5 cases per million among those over 50 years of age between 1979 and 2017. Approximately 85% of CJD cases are sporadic, and 10–15% of CJD cases are due to inherited mutations of the prion protein gene. CJD deaths and age-adjusted death rate in the United States indicate an increasing trend in the number of deaths between 1979 and 2017. Although not fully understood, additional information suggests that CJD rates in nonwhite groups are lower than in whites. While the mean onset is approximately 67 years of age, cases of sCJD have been reported as young as 17 years and over 80 years of age. Mental capabilities rapidly deteriorate and the average amount of time from onset of symptoms to death is 7 to 9 months. According to a 2020 systematic review on the international epidemiology of CJD:
== Hadamard transform time-of-flight mass spectrometry == Hadamard transform time-of flight mass spectrometry (HT-TOFMS) is a mode of mass analysis used to significantly increase the signal-to-noise ratio of a conventional TOFMS. Whereas traditional TOFMS analyzes one packet of ions at a time, waiting for the ions to reach the detector before introducing another ion packet, HT-TOFMS can simultaneously analyze several ion packets traveling in the flight tube. The ions packets are encoded by rapidly modulating the transmission of the ion beam, so that lighter (and thus faster) ions from all initially released packets of mass from a beam get ahead of heavier (and thus slower) ions. This process creates an overlap of many time-of-flight distributions convoluted in form of signals. The Hadamard transform algorithm is then used to carry out the deconvolution process which helps to produce a faster mass spectral storage rate than traditional TOFMS and other comparable mass separation instruments.
Sources: en.wikipedia.org
Karl Fischer titration is widely used because it is specific for water and works at low levels. Loss on drying is simpler but less specific, since volatile solvents or decomposition products can also be lost.
Collapse can occur when the product temperature exceeds its critical formulation temperature during drying. The porous structure then melts or shrinks, reducing reconstitution speed and sometimes altering stability.
No. Low moisture slows many degradation pathways but does not stop oxidation, hydrolysis, or physical changes completely. Storage temperature, container closure, and formulation still influence shelf life.
Primary drying removes ice by sublimation under vacuum. Secondary drying removes water that is bound to the material, often by warming the product after most ice has left. Both stages occur below temperatures that would cause unwanted melting.